Rapid Nutrition Secures Distribution for Azurene and SystemLS Brands in Korea and Japan
London, United Kingdom – 4 September 2024 - Rapid Nutrition PLC (Euronext Growth Paris: ALRPD), a global leader in natural wellness products, is pleased to announce that it has secured distribution agreement for its flagship immunity product, Azurene, as well as its SystemLS brand, in the key markets of Korea and Japan.
This significant milestone marks the culmination of six months of strategic negotiations and meticulous planning, as Rapid Nutrition continues to expand its footprint in the Asia-Pacific region. The company has partnered with Familink, a highly respected distributor in Korea with extensive experience in the health and wellness sector. Familink's strong market presence and deep industry knowledge will play a pivotal role in the successful introduction and growth of Rapid Nutrition’s products in these new markets.
"We are thrilled to bring Azurene and SystemLS to consumers in Korea and Japan," said Simon St. Ledger, CEO of Rapid Nutrition. "Our management team has worked diligently to secure this exclusive partnership, and we are confident that Familink’s expertise will help us reach and exceed our goals in these markets. This expansion represents a major step forward in our global growth strategy, allowing us to bring our science-backed wellness products to even more consumers."
The entry into Korea and Japan complements the company’s recent expansion into China, aligning with its broader strategy to capitalize on the growing demand for health and wellness products across Asia. These agreements not only reinforce the company’s commitment to expanding its global distribution network but also underscore the strong potential in these highly competitive markets. The company anticipates that the benefits of these strategic moves will not only bolster its market presence but also drive significant additional revenue, which is expected to materialize in the latter half of the year.
Rapid Nutrition's expansion into Korea and Japan builds on its successful entry into China earlier this year, where the company has already seen strong traction. With the addition of Korea and Japan, Rapid Nutrition is poised to significantly increase its market share in Asia, further solidifying its position as a leading provider of high-quality, natural health products.
For more information about Rapid Nutrition PLC and its product offerings, including market insights, please visit www.rnplc.com.
About Rapid Nutrition
Rapid Nutrition is a leading health and wellness company committed to providing innovative solutions for a healthier world. With a focus on research-backed formulas, we empower individuals to optimize their well-being and face life's challenges with confidence.
Investor Relations Contact:
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).